Global Contraceptives Drugs and Devices Market Insights and Forecast to 2028

Publisher Name :
Date: 21-Feb-2022
No. of pages: 107
Inquire Before Buying

Contraceptives Drugs and Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Contraceptives Drugs and Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)

- Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

Segment by Application

- Female

- Male

By Company

- Teva Pharmaceutical Industries Ltd

- Church & Dwight Co. Inc

- Reckitt Benckiser Plc

- Pfizer, Inc

- Bayer AG

- Mayer Laboratories, Inc

- The Female Health Company

- Cooper Surgical, Inc

- Allergan plc

- Cipla Limited

- Merck & Co. Inc

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Contraceptives Drugs and Devices Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Contraceptives Drugs and Devices Product Introduction
1.2 Market by Type
1.2.1 Global Contraceptives Drugs and Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
1.2.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
1.3 Market by Application
1.3.1 Global Contraceptives Drugs and Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Female
1.3.3 Male
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Contraceptives Drugs and Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Contraceptives Drugs and Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Contraceptives Drugs and Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Contraceptives Drugs and Devices Sales by Region
2.4.1 Global Contraceptives Drugs and Devices Sales by Region (2017-2022)
2.4.2 Global Sales Contraceptives Drugs and Devices by Region (2023-2028)
2.5 Global Contraceptives Drugs and Devices Revenue by Region
2.5.1 Global Contraceptives Drugs and Devices Revenue by Region (2017-2022)
2.5.2 Global Contraceptives Drugs and Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Contraceptives Drugs and Devices Sales by Manufacturers
3.1.1 Global Top Contraceptives Drugs and Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Contraceptives Drugs and Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Contraceptives Drugs and Devices in 2021
3.2 Global Contraceptives Drugs and Devices Revenue by Manufacturers
3.2.1 Global Contraceptives Drugs and Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Contraceptives Drugs and Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Contraceptives Drugs and Devices Revenue in 2021
3.3 Global Contraceptives Drugs and Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Contraceptives Drugs and Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Contraceptives Drugs and Devices Sales by Type
4.1.1 Global Contraceptives Drugs and Devices Historical Sales by Type (2017-2022)
4.1.2 Global Contraceptives Drugs and Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Contraceptives Drugs and Devices Sales Market Share by Type (2017-2028)
4.2 Global Contraceptives Drugs and Devices Revenue by Type
4.2.1 Global Contraceptives Drugs and Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Contraceptives Drugs and Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Contraceptives Drugs and Devices Revenue Market Share by Type (2017-2028)
4.3 Global Contraceptives Drugs and Devices Price by Type
4.3.1 Global Contraceptives Drugs and Devices Price by Type (2017-2022)
4.3.2 Global Contraceptives Drugs and Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Contraceptives Drugs and Devices Sales by Application
5.1.1 Global Contraceptives Drugs and Devices Historical Sales by Application (2017-2022)
5.1.2 Global Contraceptives Drugs and Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Contraceptives Drugs and Devices Sales Market Share by Application (2017-2028)
5.2 Global Contraceptives Drugs and Devices Revenue by Application
5.2.1 Global Contraceptives Drugs and Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Contraceptives Drugs and Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Contraceptives Drugs and Devices Revenue Market Share by Application (2017-2028)
5.3 Global Contraceptives Drugs and Devices Price by Application
5.3.1 Global Contraceptives Drugs and Devices Price by Application (2017-2022)
5.3.2 Global Contraceptives Drugs and Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Contraceptives Drugs and Devices Market Size by Type
6.1.1 North America Contraceptives Drugs and Devices Sales by Type (2017-2028)
6.1.2 North America Contraceptives Drugs and Devices Revenue by Type (2017-2028)
6.2 North America Contraceptives Drugs and Devices Market Size by Application
6.2.1 North America Contraceptives Drugs and Devices Sales by Application (2017-2028)
6.2.2 North America Contraceptives Drugs and Devices Revenue by Application (2017-2028)
6.3 North America Contraceptives Drugs and Devices Market Size by Country
6.3.1 North America Contraceptives Drugs and Devices Sales by Country (2017-2028)
6.3.2 North America Contraceptives Drugs and Devices Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Contraceptives Drugs and Devices Market Size by Type
7.1.1 Europe Contraceptives Drugs and Devices Sales by Type (2017-2028)
7.1.2 Europe Contraceptives Drugs and Devices Revenue by Type (2017-2028)
7.2 Europe Contraceptives Drugs and Devices Market Size by Application
7.2.1 Europe Contraceptives Drugs and Devices Sales by Application (2017-2028)
7.2.2 Europe Contraceptives Drugs and Devices Revenue by Application (2017-2028)
7.3 Europe Contraceptives Drugs and Devices Market Size by Country
7.3.1 Europe Contraceptives Drugs and Devices Sales by Country (2017-2028)
7.3.2 Europe Contraceptives Drugs and Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Contraceptives Drugs and Devices Market Size by Type
8.1.1 Asia Pacific Contraceptives Drugs and Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Contraceptives Drugs and Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Contraceptives Drugs and Devices Market Size by Application
8.2.1 Asia Pacific Contraceptives Drugs and Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Contraceptives Drugs and Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Contraceptives Drugs and Devices Market Size by Region
8.3.1 Asia Pacific Contraceptives Drugs and Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Contraceptives Drugs and Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Contraceptives Drugs and Devices Market Size by Type
9.1.1 Latin America Contraceptives Drugs and Devices Sales by Type (2017-2028)
9.1.2 Latin America Contraceptives Drugs and Devices Revenue by Type (2017-2028)
9.2 Latin America Contraceptives Drugs and Devices Market Size by Application
9.2.1 Latin America Contraceptives Drugs and Devices Sales by Application (2017-2028)
9.2.2 Latin America Contraceptives Drugs and Devices Revenue by Application (2017-2028)
9.3 Latin America Contraceptives Drugs and Devices Market Size by Country
9.3.1 Latin America Contraceptives Drugs and Devices Sales by Country (2017-2028)
9.3.2 Latin America Contraceptives Drugs and Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Contraceptives Drugs and Devices Market Size by Type
10.1.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Contraceptives Drugs and Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Contraceptives Drugs and Devices Market Size by Application
10.2.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Contraceptives Drugs and Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Contraceptives Drugs and Devices Market Size by Country
10.3.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Contraceptives Drugs and Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva Pharmaceutical Industries Ltd
11.1.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.1.2 Teva Pharmaceutical Industries Ltd Overview
11.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.2 Church & Dwight Co. Inc
11.2.1 Church & Dwight Co. Inc Corporation Information
11.2.2 Church & Dwight Co. Inc Overview
11.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Church & Dwight Co. Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Church & Dwight Co. Inc Recent Developments
11.3 Reckitt Benckiser Plc
11.3.1 Reckitt Benckiser Plc Corporation Information
11.3.2 Reckitt Benckiser Plc Overview
11.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Reckitt Benckiser Plc Recent Developments
11.4 Pfizer, Inc
11.4.1 Pfizer, Inc Corporation Information
11.4.2 Pfizer, Inc Overview
11.4.3 Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer, Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer, Inc Recent Developments
11.5 Bayer AG
11.5.1 Bayer AG Corporation Information
11.5.2 Bayer AG Overview
11.5.3 Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer AG Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer AG Recent Developments
11.6 Mayer Laboratories, Inc
11.6.1 Mayer Laboratories, Inc Corporation Information
11.6.2 Mayer Laboratories, Inc Overview
11.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Mayer Laboratories, Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mayer Laboratories, Inc Recent Developments
11.7 The Female Health Company
11.7.1 The Female Health Company Corporation Information
11.7.2 The Female Health Company Overview
11.7.3 The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 The Female Health Company Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 The Female Health Company Recent Developments
11.8 Cooper Surgical, Inc
11.8.1 Cooper Surgical, Inc Corporation Information
11.8.2 Cooper Surgical, Inc Overview
11.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cooper Surgical, Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cooper Surgical, Inc Recent Developments
11.9 Allergan plc
11.9.1 Allergan plc Corporation Information
11.9.2 Allergan plc Overview
11.9.3 Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Allergan plc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Allergan plc Recent Developments
11.10 Cipla Limited
11.10.1 Cipla Limited Corporation Information
11.10.2 Cipla Limited Overview
11.10.3 Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Cipla Limited Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cipla Limited Recent Developments
11.11 Merck & Co. Inc
11.11.1 Merck & Co. Inc Corporation Information
11.11.2 Merck & Co. Inc Overview
11.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Merck & Co. Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Merck & Co. Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Contraceptives Drugs and Devices Industry Chain Analysis
12.2 Contraceptives Drugs and Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Contraceptives Drugs and Devices Production Mode & Process
12.4 Contraceptives Drugs and Devices Sales and Marketing
12.4.1 Contraceptives Drugs and Devices Sales Channels
12.4.2 Contraceptives Drugs and Devices Distributors
12.5 Contraceptives Drugs and Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Contraceptives Drugs and Devices Industry Trends
13.2 Contraceptives Drugs and Devices Market Drivers
13.3 Contraceptives Drugs and Devices Market Challenges
13.4 Contraceptives Drugs and Devices Market Restraints
14 Key Findings in The Global Contraceptives Drugs and Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Contraceptives Drugs and Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Table 3. Major Manufacturers of Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Table 4. Global Contraceptives Drugs and Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Contraceptives Drugs and Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Contraceptives Drugs and Devices Sales by Region (2017-2022) & (K Units)
Table 7. Global Contraceptives Drugs and Devices Sales Market Share by Region (2017-2022)
Table 8. Global Contraceptives Drugs and Devices Sales by Region (2023-2028) & (K Units)
Table 9. Global Contraceptives Drugs and Devices Sales Market Share by Region (2023-2028)
Table 10. Global Contraceptives Drugs and Devices Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Contraceptives Drugs and Devices Revenue Market Share by Region (2017-2022)
Table 12. Global Contraceptives Drugs and Devices Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Contraceptives Drugs and Devices Revenue Market Share by Region (2023-2028)
Table 14. Global Contraceptives Drugs and Devices Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Contraceptives Drugs and Devices Sales Share by Manufacturers (2017-2022)
Table 16. Global Contraceptives Drugs and Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Contraceptives Drugs and Devices Revenue Share by Manufacturers (2017-2022)
Table 18. Contraceptives Drugs and Devices Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Contraceptives Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Contraceptives Drugs and Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs and Devices as of 2021)
Table 21. Contraceptives Drugs and Devices Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Contraceptives Drugs and Devices Product Offered
Table 23. Date of Manufacturers Enter into Contraceptives Drugs and Devices Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Contraceptives Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 26. Global Contraceptives Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 27. Global Contraceptives Drugs and Devices Sales Share by Type (2017-2022)
Table 28. Global Contraceptives Drugs and Devices Sales Share by Type (2023-2028)
Table 29. Global Contraceptives Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Contraceptives Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Contraceptives Drugs and Devices Revenue Share by Type (2017-2022)
Table 32. Global Contraceptives Drugs and Devices Revenue Share by Type (2023-2028)
Table 33. Contraceptives Drugs and Devices Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Contraceptives Drugs and Devices Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Contraceptives Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 36. Global Contraceptives Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 37. Global Contraceptives Drugs and Devices Sales Share by Application (2017-2022)
Table 38. Global Contraceptives Drugs and Devices Sales Share by Application (2023-2028)
Table 39. Global Contraceptives Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Contraceptives Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Contraceptives Drugs and Devices Revenue Share by Application (2017-2022)
Table 42. Global Contraceptives Drugs and Devices Revenue Share by Application (2023-2028)
Table 43. Contraceptives Drugs and Devices Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Contraceptives Drugs and Devices Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Contraceptives Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 46. North America Contraceptives Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 47. North America Contraceptives Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Contraceptives Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Contraceptives Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 50. North America Contraceptives Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 51. North America Contraceptives Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Contraceptives Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Contraceptives Drugs and Devices Sales by Country (2017-2022) & (K Units)
Table 54. North America Contraceptives Drugs and Devices Sales by Country (2023-2028) & (K Units)
Table 55. North America Contraceptives Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Contraceptives Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Contraceptives Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 58. Europe Contraceptives Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 59. Europe Contraceptives Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Contraceptives Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Contraceptives Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 62. Europe Contraceptives Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 63. Europe Contraceptives Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Contraceptives Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Contraceptives Drugs and Devices Sales by Country (2017-2022) & (K Units)
Table 66. Europe Contraceptives Drugs and Devices Sales by Country (2023-2028) & (K Units)
Table 67. Europe Contraceptives Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Contraceptives Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Contraceptives Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Contraceptives Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Contraceptives Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Contraceptives Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Contraceptives Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Contraceptives Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Contraceptives Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Contraceptives Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Contraceptives Drugs and Devices Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Contraceptives Drugs and Devices Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Contraceptives Drugs and Devices Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Contraceptives Drugs and Devices Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Contraceptives Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Contraceptives Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Contraceptives Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Contraceptives Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Contraceptives Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Contraceptives Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Contraceptives Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Contraceptives Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Contraceptives Drugs and Devices Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Contraceptives Drugs and Devices Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Contraceptives Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Contraceptives Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Contraceptives Drugs and Devices Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Contraceptives Drugs and Devices Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Contraceptives Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Contraceptives Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Contraceptives Drugs and Devices Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Contraceptives Drugs and Devices Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Contraceptives Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Contraceptives Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Contraceptives Drugs and Devices Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Contraceptives Drugs and Devices Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Contraceptives Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Contraceptives Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 105. Teva Pharmaceutical Industries Ltd Corporation Information
Table 106. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 107. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Teva Pharmaceutical Industries Ltd Recent Developments
Table 110. Church & Dwight Co. Inc Corporation Information
Table 111. Church & Dwight Co. Inc Description and Major Businesses
Table 112. Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Church & Dwight Co. Inc Recent Developments
Table 115. Reckitt Benckiser Plc Corporation Information
Table 116. Reckitt Benckiser Plc Description and Major Businesses
Table 117. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Reckitt Benckiser Plc Recent Developments
Table 120. Pfizer, Inc Corporation Information
Table 121. Pfizer, Inc Description and Major Businesses
Table 122. Pfizer, Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Pfizer, Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Pfizer, Inc Recent Developments
Table 125. Bayer AG Corporation Information
Table 126. Bayer AG Description and Major Businesses
Table 127. Bayer AG Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Bayer AG Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Bayer AG Recent Developments
Table 130. Mayer Laboratories, Inc Corporation Information
Table 131. Mayer Laboratories, Inc Description and Major Businesses
Table 132. Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Mayer Laboratories, Inc Recent Developments
Table 135. The Female Health Company Corporation Information
Table 136. The Female Health Company Description and Major Businesses
Table 137. The Female Health Company Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. The Female Health Company Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. The Female Health Company Recent Developments
Table 140. Cooper Surgical, Inc Corporation Information
Table 141. Cooper Surgical, Inc Description and Major Businesses
Table 142. Cooper Surgical, Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Cooper Surgical, Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Cooper Surgical, Inc Recent Developments
Table 145. Allergan plc Corporation Information
Table 146. Allergan plc Description and Major Businesses
Table 147. Allergan plc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Allergan plc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Allergan plc Recent Developments
Table 150. Cipla Limited Corporation Information
Table 151. Cipla Limited Description and Major Businesses
Table 152. Cipla Limited Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Cipla Limited Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Cipla Limited Recent Developments
Table 155. Merck & Co. Inc Corporation Information
Table 156. Merck & Co. Inc Description and Major Businesses
Table 157. Merck & Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Merck & Co. Inc Contraceptives Drugs and Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Merck & Co. Inc Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Contraceptives Drugs and Devices Distributors List
Table 163. Contraceptives Drugs and Devices Customers List
Table 164. Contraceptives Drugs and Devices Market Trends
Table 165. Contraceptives Drugs and Devices Market Drivers
Table 166. Contraceptives Drugs and Devices Market Challenges
Table 167. Contraceptives Drugs and Devices Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Contraceptives Drugs and Devices Product Picture
Figure 3. Global Contraceptives Drugs and Devices Market Share by Type in 2021 & 2028
Figure 3. Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Product Picture
Figure 4. Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Product Picture
Figure 5. Global Contraceptives Drugs and Devices Market Share by Application in 2021 & 2028
Figure 6. Female
Figure 7. Male
Figure 8. Contraceptives Drugs and Devices Report Years Considered
Figure 9. Global Contraceptives Drugs and Devices Sales 2017-2028 (K Units)
Figure 10. Global Contracept
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs